Levocetirizine Impurity E is a degradation byproduct formed via oxidative cleavage of the ethyl side chain in the piperidine ring of the parent antihistamine. It retains the core chlorophenoxyacetyl moiety but features a truncated aliphatic chain with a terminal carboxylic acid group, replacing the original ethyl ester. This structural modification introduces an additional asymmetric center, resulting in a diastereomeric configuration distinct from Levocetirizine. The compound serves as a critical HPLC reference standard for quantifying process-related impurities in Levocetirizine drug substance synthesis.
On RequestC1CN(CCN1CCOCCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
InChI=1S/C23H29ClN2O4/c24-21-8-6-20(7-9-21)23(19-4-2-1-3-5-19)26-12-10-25(11-13-26)14-15-29-16-17-30-18-22(27)28/h1-9,23H,10-18H2,(H,27,28)
AIOFDOGAYXDHHG-UHFFFAOYSA-N